Abstract

Introduction The presence of pulmonary arteriovenous malformations (PAVMs) is associated with hypoxaemia due to shunting of deoxygenated blood from pulmonary arteries to veins. Evaluation of exercise capacity is problematic using usual dyspnoea scales, since the majority of patients are in Medical Research Council or New York Heart Association Class 1 (normal) pre-treatment, even when oxygen saturation of haemoglobin (SaO2) is Method Potential methods suitable for PAVM patient exercise ranges were evaluated. In March 2017, a UK-modified version of the Veterans Specific Activity Questionnaire (VSAQ) was developed and incorporated into routine clinic assessments. This validated, simple 13 point self-reported scale permits calculation of the achieved metabolic equivalents (METs) where METS=4.7+0.97(VSAQ)−0.06(age). With ethical approval, the VSAQ results were compared to other routine clinic and research assessments including research protocol CPET. Results Between 16/03/2017 and 14/05/2018, 115 PAVM patients completed the VSAQ in clinic. All had PAVMs proven by CT scan, with erect SaO2 ranging from 80% to 99.5% (median 96%). Only 27/115 (23.4%) reported needing to stop at activities less energetic than walking briskly at 4 miles per hour. Overall METS ranged from 1.33 to 16.39 kcal/kg/hour (median 8.51, IQR 6.42, 11.92). In univariate analyses, the strongest predictor of METS was the forced expiratory volume in 1 s (FEV1, p=0.001), and not SaO2 (p=0.052). However, once adjusted for FEV1, lower SaO2 were more strongly associated with lower METS (adjusted p-value 0.019). Six patients had also undergone research protocol CPET. In this group, METs was strongly predicted by VO2 peak (adjusted r2 0.78, p=0.013) or anaerobic threshold (adjusted r2 0.65, p=0.032). Conclusions The VSAQ is a useful and quantifiable measure of exercise capacity that can be readily employed in clinical service. The scale differentials permit sub-categorisation of individuals with normal exercise tolerance, while also evaluating classifying those with more severe dyspnoea. Comparison of VSAQ and CPET results demonstrate it may be a useful substitute to integrate into wider clinical practice. Reference Santhirapala, et al. PLoS One2014:9(3):e90777. doi:10.1371/journal.pone.0090777

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.